Increased Lymphatic Vessels: A Risk Factor for Severe Renal Function Loss in Obstructive Nephropathy Patients

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2024 Sep 23

PMID 39310255

Authors

Zheng Wang

Danni Hu

Huzi Xu

Rui Zeng

Ying Yao

Affiliations

Soon will be listed here.

Abstract

Obstructive nephropathy (ON), resulting from hindered urine flow, significantly contributes to both acute kidney injury (AKI) and chronic kidney disease (CKD). Research has consistently highlighted increased lymphatic vessels (LVs) density in diverse kidney diseases. However, the precise involvement of LVs in ON remains unclear. Patients diagnosed with ON were enrolled in this study from January 2020 to December 2023. LVs and histological pathology in renal biopsy tissues were detected through immunohistochemistry and Periodic Acid-Schiff staining. Patients were categorized into two cohorts based on their estimated glomerular filtration rate (eGFR) levels: one cohort included patients with eGFR < 90, while the other encompassed those with eGFR ≥ 90. Univariate and multivariable logistic regression analyses were conducted to determine the odds ratio (OR) and 95% confidence interval (CI) for the association between the two cohorts. 239 patients were enrolled in the study. The density of LVs was elevated in ON, with even higher densities observed in patients with severe renal impairment. Additionally, several risk factors contributing to the deterioration of renal function in ON patients have been identified, including age, ureteral calculi (UC), alanine aminotransferase (ALT), and uric acid (UA). Furthermore, by leveraging LVs density, multiple robust models have been established to predict severe renal impairment in ON. Lymphatic vessels density is significantly elevated in ON, serving as an independent risk factor for the decline in renal function.

References

Srinivasan R, Escobedo N, Yang Y, Interiano A, Dillard M, Finkelstein D . The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors. Genes Dev. 2014; 28(19):2175-87. PMC: 4180978. DOI: 10.1101/gad.216226.113. View

Corbo J, Wang J . Kidney and Ureteral Stones. Emerg Med Clin North Am. 2019; 37(4):637-648. DOI: 10.1016/j.emc.2019.07.004. View

Chooi Y, Ding C, Magkos F . The epidemiology of obesity. Metabolism. 2018; 92:6-10. DOI: 10.1016/j.metabol.2018.09.005. View

Long D, Norman J, Fine L . Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol. 2012; 8(4):244-50. DOI: 10.1038/nrneph.2011.219. View

Bianchi R, Russo E, Bachmann S, Proulx S, Sesartic M, Smaadahl N . Postnatal Deletion of Podoplanin in Lymphatic Endothelium Results in Blood Filling of the Lymphatic System and Impairs Dendritic Cell Migration to Lymph Nodes. Arterioscler Thromb Vasc Biol. 2016; 37(1):108-117. DOI: 10.1161/ATVBAHA.116.308020. View

Taylor E, Stampfer M, Curhan G . Obesity, weight gain, and the risk of kidney stones. JAMA. 2005; 293(4):455-62. DOI: 10.1001/jama.293.4.455. View

Donnan M, Kenig-Kozlovsky Y, Quaggin S . The lymphatics in kidney health and disease. Nat Rev Nephrol. 2021; 17(10):655-675. DOI: 10.1038/s41581-021-00438-y. View

Vosough Z, Golbini S, Sharbatdaran M, Hosseini A . D2-40 A Helpful Marker in Assessment of Lymphatic Vessel Invasion in Carcinoma of Breast. Iran J Pathol. 2021; 16(2):96-102. PMC: 8085290. DOI: 10.30699/IJP.2020.114511.2245. View

Kellum J, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H . Acute kidney injury. Nat Rev Dis Primers. 2021; 7(1):52. DOI: 10.1038/s41572-021-00284-z. View

10.

Hu D, Wang Z, Wang S, Li Y, Pei G, Zeng R . Lymphatic vessels in patients with crescentic glomerulonephritis: association with renal pathology and prognosis. J Nephrol. 2024; 37(5):1285-1298. DOI: 10.1007/s40620-024-01903-0. View

11.

Yazdani S, Poosti F, Kramer A, Mirkovic K, Kwakernaak A, Hovingh M . Proteinuria triggers renal lymphangiogenesis prior to the development of interstitial fibrosis. PLoS One. 2012; 7(11):e50209. PMC: 3506584. DOI: 10.1371/journal.pone.0050209. View

12.

Zhang T, Guan G, Liu G, Sun J, Chen B, Li X . Disturbance of lymph circulation develops renal fibrosis in rats with or without contralateral nephrectomy. Nephrology (Carlton). 2008; 13(2):128-38. DOI: 10.1111/j.1440-1797.2007.00851.x. View

13.

Ronco C, Bellomo R, Kellum J . Acute kidney injury. Lancet. 2019; 394(10212):1949-1964. DOI: 10.1016/S0140-6736(19)32563-2. View

14.

Akposso K, Hertig A, Couprie R, Flahaut A, Alberti C, Karras G . Acute renal failure in patients over 80 years old: 25-years' experience. Intensive Care Med. 2000; 26(4):400-6. DOI: 10.1007/s001340051173. View

15.

Johnson L, Banerji S, Lawrance W, Gileadi U, Prota G, Holder K . Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1. Nat Immunol. 2017; 18(7):762-770. DOI: 10.1038/ni.3750. View

16.

Sakamoto I, Ito Y, Mizuno M, Suzuki Y, Sawai A, Tanaka A . Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int. 2009; 75(8):828-38. DOI: 10.1038/ki.2008.661. View

17.

Thongprayoon C, Krambeck A, Rule A . Determining the true burden of kidney stone disease. Nat Rev Nephrol. 2020; 16(12):736-746. DOI: 10.1038/s41581-020-0320-7. View

18.

Lee H, Qin Y, Kim Y, Park E, Hwang J, Huo G . Expression of lymphatic endothelium-specific hyaluronan receptor LYVE-1 in the developing mouse kidney. Cell Tissue Res. 2010; 343(2):429-44. DOI: 10.1007/s00441-010-1098-x. View

19.

Pei G, Yao Y, Yang Q, Wang M, Wang Y, Wu J . Lymphangiogenesis in kidney and lymph node mediates renal inflammation and fibrosis. Sci Adv. 2019; 5(6):eaaw5075. PMC: 6594767. DOI: 10.1126/sciadv.aaw5075. View

20.

Glassock R, Warnock D, Delanaye P . The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2016; 13(2):104-114. DOI: 10.1038/nrneph.2016.163. View